Biogen Inc (NAS:BIIB)
$ 210.73 -1.77 (-0.83%) Market Cap: 31.14 Bil Enterprise Value: 38.21 Bil PE Ratio: 37.30 PB Ratio: 1.65 GF Score: 73/100

Biogen Inc. at Wells Fargo Healthcare Conference Transcript

Sep 09, 2026 / 01:30PM GMT
Release Date Price: $210.73 (-0.83%)
Unidentified Participant

Awesome.

Thank you very much.

Thank you everyone for joining us today, session two for me.

So we have Biogen management team with us today. We have Robin Kramer, the Chief Financial Officer of the company, and we also are joined by Aaron Keeney, the head of corporate development of the company.

Thank you very much for joining us today.

Robin Kramer
Biogen Inc. - Senior Vice President, Chief Accounting Officer

Thank you for having us.

Questions & Answers

Unidentified Participant

Great. So I think I'm hosting you for the first time at the Wells Fargo conference. So again, thank you very much, you and Tim and our team basically.

For making it happen. So Robin, it has been one and a half years for you as the CFO of the company and a lot has changed at Biogen in those 18 months. So from your lenses, where do you think Biogen has done really well in those 18 months or so?

And where do you think that you see the room for improvement as there is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot